On March 11th 2021, Biolyse Pharma (“Biolyse”) issued a statement publicly indicating their capacity to manufacture a COVID-19 vaccine and their intent to apply for a compulsory license in Canada. Biolyse is a Canadian manufacturer of cancer drugs based out… Continue Reading
On June 8, 2021, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) concerning the “Prospective Grant of an Exclusive Patent License: Methods and Compositions for Adoptive Cell Therapy” (86 FR 27852). The inventions to be… Continue Reading
Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) on June 8, 2021 regarding the “Prospective Grant of an Exclusive Patent License: P2Y14 Receptor Antagonists To Treat Kidney and Lung Inflammation” (86 FR 27858). The license… Continue Reading
On June 2, 2021, Knowledge Ecology International (KEI) filed comments with the National Institutes of Health (NIH) regarding the “Prospective Grant of an Exclusive Patent License: Development, Commercialization, and Use of Protein-Based Vaccines Expressing Recombinant Measles and Mumps Immunogens for… Continue Reading
On 12 May 2021, Antigua and Barbuda notified the World Trade Organization (WTO) of their general intent to use the compulsory license system provided under article 31bis of the amended Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). This… Continue Reading
Knowledge Ecology International (KEI) has obtained an document authored by the European Union which outlines a counter-proposal to the proposed TRIPS waiver. It is expected that the European Union will formally submit its counter-proposal to the World Trade Organization (WTO)… Continue Reading
At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on “Public health emergencies: preparedness and response” on Monday, 31 May 2021. Non-state actors are limited to one minute statements. Knowledge Ecology International asks… Continue Reading
At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on WHO’s global strategy and plan of action on public health, innovation, and intellectual property on Saturday, 29 May 2021. Non-state actors are limited… Continue Reading
At the World Health Organization’s 74th World Health Assembly, Knowledge Ecology International delivered the following remarks on expanding access to effective treatments for cancer and rare and orphan diseases including cell and gene-based therapies on Thursday, 27 May 2021. Non-state… Continue Reading
On Friday, 21 May 2021, 62 WTO members (African Group, the Plurinational State of Bolivia, Egypt, Eswatini, Fiji, India, Indonesia, Kenya, the LDC Group, Maldives, Mozambique, Mongolia, Namibia, Pakistan, South Africa, Vanuatu, the Bolivarian Republic of Venezuela and Zimbabwe) submitted… Continue Reading
Ahead of the 74th World Health Assembly, Health Action International, Knowledge Ecology International, and Medicines Law & Policy will be co-hosting a discussion with a high-level panel on what a pandemic response treaty should say about the sharing of rights… Continue Reading